At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
IVA Inventiva S.A.
Trading 09-15 13:41:10 EDT
3.77
-0.11
-2.96%
High4.03Low3.74Vol1.54M
Open3.90D1 Closing3.88Amplitude7.35%
Mkt Cap888.54MTradable Cap677.70MTotal Shares236.00M
T/O6.06MT/O Rate0.86%Tradable Shares180.00M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Analysts Have Conflicting Sentiments on These Healthcare Companies: SanBio Co (OtherSNBIF), Immutep Ltd (OtherPRRUF) and Inventiva (IVA)
TIPRANKS  ·  09-15 20:20
Analysts Have Conflicting Sentiments on These Healthcare Companies: SanBio Co (OtherSNBIF), Immutep Ltd (OtherPRRUF) and Inventiva (IVA)
Inventiva price target raised to $14 from $11 at Guggenheim
TIPRANKS  ·  09-15 20:15
Inventiva price target raised to $14 from $11 at Guggenheim
Guggenheim Sticks to Its Buy Rating for Inventiva (IVA)
TIPRANKS  ·  09-15 19:35
Guggenheim Sticks to Its Buy Rating for Inventiva (IVA)
Inventiva Says All Patients Completed 72-Week Treatment Period in Phase 3 Liver Disease Study
MT Newswires Live  ·  09-03
Inventiva Says All Patients Completed 72-Week Treatment Period in Phase 3 Liver Disease Study
Inventiva announces last patient visit in NATiV3 trial
TIPRANKS  ·  09-03
Inventiva announces last patient visit in NATiV3 trial
Inventiva Names Chris Benecchi COO
MT Newswires Live  ·  09-01
Inventiva Names Chris Benecchi COO
Inventiva appoints Chris Benecchi as COO
TIPRANKS  ·  09-01
Inventiva appoints Chris Benecchi as COO
Wall Street Analysts Are Bullish on Top Healthcare Picks
TIPRANKS  ·  07-27
Wall Street Analysts Are Bullish on Top Healthcare Picks
Inventiva Initiated at Overweight by Cantor Fitzgerald
Dow Jones  ·  07-17
Inventiva Initiated at Overweight by Cantor Fitzgerald
European Equities Traded in the US as American Depositary Receipts Decline Friday
MT Newswires Live  ·  07-10
European Equities Traded in the US as American Depositary Receipts Decline Friday
European Equities Traded in the US as American Depositary Receipts Rise Thursday
MT Newswires Live  ·  07-09
European Equities Traded in the US as American Depositary Receipts Rise Thursday
Press Release: Results of the Votes of the Combined Shareholders' General Meeting of June 30, 2026
Dow Jones  ·  07-03
Press Release: Results of the Votes of the Combined Shareholders' General Meeting of June 30, 2026
Analysts Offer Insights on Healthcare Companies: Inventiva (IVA), Rhythm Pharmaceuticals (RYTM) and Belite Bio, Inc. ADR (BLTE)
TIPRANKS  ·  06-15
Analysts Offer Insights on Healthcare Companies: Inventiva (IVA), Rhythm Pharmaceuticals (RYTM) and Belite Bio, Inc. ADR (BLTE)
Press Release: Statement of Total Voting Rights and Shares Forming The Company's Share Capital as of May 22, 2026
Dow Jones  ·  06-10
Press Release: Statement of Total Voting Rights and Shares Forming The Company's Share Capital as of May 22, 2026
Press Release: Combined General Meeting of June 30, 2026 - Availability of the Preparatory Documents
Dow Jones  ·  06-10
Press Release: Combined General Meeting of June 30, 2026 - Availability of the Preparatory Documents
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Apogee Therapeutics (APGE), Inventiva (IVA) and Roche Holding AG (OtherRHHVF)
TIPRANKS  ·  06-08
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Apogee Therapeutics (APGE), Inventiva (IVA) and Roche Holding AG (OtherRHHVF)
Inventiva (IVA) Receives a Buy from Barclays
TIPRANKS  ·  06-04
Inventiva (IVA) Receives a Buy from Barclays
Inventiva files automatic mixed securities shelf
TIPRANKS  ·  06-02
Inventiva files automatic mixed securities shelf
eGain Launches AI Agent IVA to Deliver Accurate, Conversational Customer Service
GlobeNewswire  ·  05-06
eGain Launches AI Agent IVA to Deliver Accurate, Conversational Customer Service
Inventiva Names Malkomes as CFO Ahead of Lanifibranor Phase 3 Readout
Dow Jones  ·  04-23
Inventiva Names Malkomes as CFO Ahead of Lanifibranor Phase 3 Readout

Introduction

Company Name.
Inventiva S.A.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of mucopolysaccharidoses type VI disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was founded in 2011 and is headquartered in Daix, France.
Issue price:
--